| Literature DB >> 26255311 |
Danfei Xu1, Zhuo Yang2, Donghong Zhang3, Wei Wu4, Ye Guo5, Qian Chen6, Dongsheng Xu7, Wei Cui8.
Abstract
BACKGROUND: Immunoglobulin heavy chain (IgH) gene rearrangement test is a standard tool in diagnosing B-cell lymphoma. The BIOMED-2 multiplex PCR protocol has become the most commonly used laboratory method for detecting clonal IgH gene rearrangement. However, post-PCR procedure requires manual transfer of PCR product for analysis and is time-consuming. A novel strategy using LightCycler to continuously monitor fluorescence during melting curve analysis (MCA) can overcome these shortcomings. The previous studies published on this method were all restricted to FR3 primers of BIOMED-2.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26255311 PMCID: PMC4529721 DOI: 10.1186/s13000-015-0370-5
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Fig. 1Annealing temperature gradient PCR on Ramos cell line. FR2 (left) and FR3 (right) primers were used to amplify Ramos cell line DNA with gradient annealing temperature from 58 °C to 68 °C to explore the optimal annealing temperature for both multiplex-PCR sets
Fig. 2Melting curve analysis of 17 lymphoid hyperplasia samples. NC: negative control (red line); PC: positive control (green line); X axis = temperature (°C); Y axis = −dF/dT, where F = fluorescence and T = temperature
Summary of clinical lymphoma samples analysed by MCA, PAGE and CE
| Patient | Age/sex | Diagnosis | Tissue | MCA-FR3(Tm°C) | MCA-FR2(Tm°C) | PAGE-FR2 | CE-FR2(nt) |
|---|---|---|---|---|---|---|---|
| 1 | 39/F | SLL | Inguinal LN | P(84.78) | P(86.34) | P | P(295) |
| 2 | 53/F | MCL | Intestine | P(86.17) | P(86.83) | P | P(251) |
| 3 | 54/F | CLL/SLL | Lung | P(85.44) | N | N | N |
| 4 | 61/F | MCL | Neck Skin | P(87.95) | P(87.68) | P | P(254) |
| 5 | 54/F | CLL/SLL | Tonsil | P(86.94) | P(87.18) | P | P(253) |
| 6 | 61/F | MZL | Spleen | P(84.93) | P(87.03) | P | P(285) |
| 7 | 51/F | DLBCL | Lung | P(84.89) | P(85.20) | P | P(286) |
| 8 | 47/F | B-NHL-UC | Brain | P(85.72) | N | N | N |
| 9 | 63/M | MZL | Neck Skin | P(86.17) | P(86.96) | P | P(277) |
| 10 | 49/M | MZL | Parotid Gland | P(88.54) | N | N | N |
| 11 | 66/F | CLL/SLL | Inguinal LN | P(86.80) | P(86.48) | P | P(260) |
| 12 | 77/F | B-NHL-UC | Eyelid | P(86.52) | P(85.60) | P | P(254) |
| 13 | 75/F | B-NHL-UC | Tongue | P(84.83) | P(85.50) | P | P(280) |
| 14 | 27/M | MZL | Parotid Gland | P(85.80) | P(86.64) | P | P(273) |
| 15 | 43/M | MZL | Lung | P(84.88) | P(86.69) | P | P(265) |
| 16 | 56/M | DLBCL | Spleen | N | N | N | N |
| 17 | 65/F | B-NHL-UC | Spleen | P(85.67) | N | N | N |
| 18 | 68/M | B-NHL-UC | Inguinal LN | N | P(87.14) | P | P(265) |
| 19 | 51/F | FL | Neck Skin | P(87.77) | P(87.64) | P | P(259) |
| 20 | 40/F | DLBCL | Ovary | N | N | N | N |
| 21 | 74/M | MCL | Tonsil | P(84.21) | P(85.14) | P | P(277) |
| 22 | 28/F | FL | Axillary LN | N | N | N | N |
| 23 | 50/M | DLBCL | Nasopharyngeal LN | N | N | N | N |
| 24 | 61/F | MZL | Spleen | P(83.10) | P(87.16) | P | P(272) |
| 25 | 75/F | DLBCL | Pelvic Tumor | P(86.52) | P(86.14) | UD | P(272) |
| 26 | 44/M | B-NHL-UC | Axillary LN | P(87.45) | P(87.35) | UD | P(272) |
| 27 | 73/F | MZL | Mandibular Gland | N | P(85.08) | P | P(259) |
| 28 | 68/F | DLBCL | Colon | N | N | N | N |
| 29 | 63/F | DLBCL | Axillary LN | P(86.96) | N | N | P(254/263) |
| 30 | 62/M | FL | Colon | N | N | N | N |
| 31 | 70/F | MZL | Stomach | N | N | N | N |
| 32 | 72/M | DLBCL | Pectoral LN | N | N | N | N |
| 33 | 77/F | DLBCL | Cheek Skin | N | N | N | N |
| 34 | 62/M | DLBCL | Spleen | N | P(86.25) | P | P(259) |
| 35 | 79/F | DLBCL | Tonsil | N | N | N | N |
| 36 | 58/M | DLBCL | Lung | N | P(85.18) | P | P(242) |
| 37 | 65/F | MZL | Thyroid | N | N | N | N |
| 38 | 38/M | MZL | Conjunctiva | N | P(84.45) | P | P(262) |
| 39 | 62/M | DLBCL | Neck Skin | P(86.82) | P(86.30) | P | P(248) |
| 40 | 62/F | DLBCL | Stomach | N | N | N | N |
The Tms of clonal samples tested by MCA and segment length from CE are listed in the parentheses
CLL/SLL chronic lymphocytic leukemia/small lymphocytic lymphoma, DLBCL diffuse large B-cell lymphoma, FL follicular lymphoma, MCL mantle cell lymphoma, MZL marginal zone B-cell lymphoma, B-NHL-UC unclassified B-NHL, LN Lymph node, P positive, N negative, UD undetermined
Fig. 3Comparison of PAGE, MCA and CE. a MCA of 5 lymphoma samples with FR2 primers. Sample 23 was negative, 24–27 were positive. b PAGE of the same 5 lymphoma samples. A very faint band can hardly be seen in sample 25# and 26# (in box) that is interpreted as undetermined and need to be further confirmed. c Evaluation of DNA quality. All samples including 25# and 26# have a sharp peak at identical Tm, which indicated the presence of lymphoid tissue with integrated DNA. d CE of the sample 25# and 26#. Both samples had a single peak at expected sizes
Fig. 4Minimal detection of MCA. Ramos cell line DNA was serially diluted with negative control at various percentages (50 %, 25 %, 12.5 %, 6.25 %, 3.125 %, 1.56 % and 0.78 %). After PCR, a clonal peak at 3.125 % can still been detected using both FR2 and FR3 primer sets
MCA of two different clonal DNA samples using FR2 primers
| Experiment NO. | Original | After mixing | |||
|---|---|---|---|---|---|
| Tm1 | Tm2 | △Tm | Tml | Tm2 | |
| 1 | 84.45 | 85.18 | 0.73 | 84.45 | — |
| 2 | 84.45 | 85.50 | 1.05 | 84.62 | — |
| 3 | 84.45 | 88.48 | 2.03 | 84.41 | 86.56 |
| 4 | 84.45 | 87.35 | 2.90 | 84.11 | 86.99 |
| 5 | 84.45 | 87.68 | 3.23 | 84.23 | 87.50 |
△Tm: Difference of melting temperatures of two original samples individually detected by MCA